Efficacy of bevacizumab with or without conventional chemotherapy in patients with metastatic colon cancer

Trial Profile

Efficacy of bevacizumab with or without conventional chemotherapy in patients with metastatic colon cancer

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Aug 2016

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Colon cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Aug 2016 New trial record
    • 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top